Novo said supply of Wegovy and Ozempic is in good shape after the drugs were removed from the FDA’s shortage list last week. But Eli Lilly reported slower than expected sales in the third quarter due to wholesaler destocking.
While Lilly Blames Wholesalers for Slow GLP-1 Sales, Novo’s Rival Medicine Is Flowing Read More »
Following two layoffs in less than three months, Viracta Therapeutics may have around 18 employees left to advance its efforts to bring lead product candidate nana-val to market.
Viracta Therapeutics Cuts 42% of Staff as Part of Resource Reprioritization Read More »
The president-elect has said he’ll let Robert F. Kennedy Jr. “go wild” on healthcare, while many expect a leadership change at the FTC could lower M&A scrutiny.
With Trump victorious, biotech industry’s focus turns to his plans for FDA, FTC Read More »
The investigational therapy, vesleteplirsen, had been positioned as an updated version of Sarepta’s original exon 51-skipping Duchenne muscular dystrophy drug Exondys 51.
Sarepta Halts Development of Next-Gen DMD Drug, Reports Robust Elevidys Sales Read More »
In this episode of Denatured, BioSpace’s Head of Insights Lori and guests from Teva Pharmaceuticals and TOWER Capital discuss the opportunities, regulatory challenges and uncertainty surrounding AI.
Investing in AI: Benefits, Regulatory Challenges Read More »
Driven by copycat versions of Bristol Myers Squibb’s Revlimid and Novo Nordisk’s Victoza, Teva’s generics business was again a top-performer in the third quarter, with U.S. sales growing 30% and bringing in $1.1 billion in sales.
Teva Reports Strong Generics Demand in Q3, Expects Higher 2024 Revenue Read More »
BMO Capital Markets analyst Evan Seigerman in a note to investors called Gilead’s third-quarter performance “consistent” and “steady,” while noting the company continues to demonstrate “reliable strength” in its human immunodeficiency virus business.
Gilead Beats Q3 Expectations Fueled by HIV Drug Sales, Raises Full-Year Guidance Read More »
La esquizofrenia es el trastorno psicótico más conocido y se calcula que afecta aproximadamente a un 1% de la población. Sin embargo, si se consideran todos los trastornos psicóticos, esta cifra asciende hasta un 3,5%. Los trastornos de este tipo suelen iniciarse entre lo …
Hallan diferencias de cognición entre hombre y mujer tras un brote psicótico Read More »
Cuando se habla de juegos de casino, en muchas ocasiones se piensa que el azar es lo único que intercede en estos juegos para poder ganar o conseguir los mejores premios. Sin embargo, hay mucho más que solo suerte en los jugadores. Los juegos de casino son populares tanto por …
¿Es el juego en el casino una ciencia? Un vistazo a las estrategias basadas en datos Read More »
Year-over-year BioSpace data shows there are fewer job postings live on the website and far more competition for them.
2024 Q3 Job Market Report: Biopharma Professionals Face Heavy Competition for Fewer Jobs Read More »
